publication date: Dec. 2, 2011
After Aggressive Budgetary Trimming, At $33 Million NCI’s caBIG Remains Big Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision Download PDF
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.